The field of diabetes treatment continues to experience a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. This https://amievbdm330590.blog2freedom.com/39104086/upcoming-glp-1-receptor-agonists-retatrutide-and-trizepatide